320 related articles for article (PubMed ID: 29535708)
1. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
Front Immunol; 2021; 12():759021. PubMed ID: 35154068
[TBL] [Abstract][Full Text] [Related]
3. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
[TBL] [Abstract][Full Text] [Related]
4. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
5. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes.
Brewig N; Kissenpfennig A; Malissen B; Veit A; Bickert T; Fleischer B; Mostböck S; Ritter U
J Immunol; 2009 Jan; 182(2):774-83. PubMed ID: 19124720
[TBL] [Abstract][Full Text] [Related]
6. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
[TBL] [Abstract][Full Text] [Related]
7. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
[TBL] [Abstract][Full Text] [Related]
8. Cross-presenting dendritic cells are required for control of Leishmania major infection.
Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
[TBL] [Abstract][Full Text] [Related]
9. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
[TBL] [Abstract][Full Text] [Related]
10. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
[TBL] [Abstract][Full Text] [Related]
11. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of
Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F
Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054
[TBL] [Abstract][Full Text] [Related]
13. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.
Lemoine S; Jaron B; Tabka S; Ettreiki C; Deriaud E; Zhivaki D; Le Ray C; Launay O; Majlessi L; Tissieres P; Leclerc C; Lo-Man R
J Allergy Clin Immunol; 2015 Nov; 136(5):1355-68.e1-15. PubMed ID: 25865351
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protection induced by in vitro maturated BMDCs presenting CD8
Shermeh AS; Zahedifard F; Habibzadeh S; Taheri T; Rafati S; Seyed N
Exp Parasitol; 2021 Apr; 223():108082. PubMed ID: 33581108
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.
Von Stebut E; Ehrchen JM; Belkaid Y; Kostka SL; Molle K; Knop J; Sunderkotter C; Udey MC
J Exp Med; 2003 Jul; 198(2):191-9. PubMed ID: 12860932
[TBL] [Abstract][Full Text] [Related]
17. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
19. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
[TBL] [Abstract][Full Text] [Related]
20. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.
Ramirez L; Corvo L; Duarte MC; Chávez-Fumagalli MA; Valadares DG; Santos DM; de Oliveira CI; Escutia MR; Alonso C; Bonay P; Tavares CA; Coelho EA; Soto M
Parasit Vectors; 2014 Jan; 7():3. PubMed ID: 24382098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]